Integer Holdings Corp (ITGR)
125.60
+0.01
(+0.01%)
USD |
NYSE |
May 02, 16:00
125.60
0.00 (0.00%)
After-Hours: 20:00
Key Stats
Price and Performance | |
---|---|
Market Cap | 4.382B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 14.40% |
Valuation | |
PE Ratio | 59.53 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 2.533 |
Price to Book Value | 2.728 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.7688 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 48.72% |
Profile
Edit
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States. |
URL | https://www.integer.net |
Investor Relations URL | https://investor.integer.net |
HQ State/Province | Texas |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Next Earnings Release | Jul. 25, 2025 (est.) |
Last Earnings Release | Apr. 24, 2025 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Edit
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States. |
URL | https://www.integer.net |
Investor Relations URL | https://investor.integer.net |
HQ State/Province | Texas |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Next Earnings Release | Jul. 25, 2025 (est.) |
Last Earnings Release | Apr. 24, 2025 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |